Theragenics (FRA:THX) Total Assets : €80.93 Mil (As of Jun. 2013)

View and export this data going back to . Start your Free Trial

What is Theragenics Total Assets?

Theragenics's Total Assets for the quarter that ended in Jun. 2013 was €80.93 Mil.

Total Assets is connected with ROA %. Theragenics's annualized ROA % for the quarter that ended in Jun. 2013 was -0.05%. Total Assets is also linked to Revenue through Asset Turnover. Theragenics's Asset Turnover for the quarter that ended in Jun. 2013 was 0.19.

Theragenics Total Assets Historical Data

The historical data trend for Theragenics's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theragenics Total Assets Chart

Theragenics Annual Data

Trend

Dec03

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Total Assets

Get a 7-Day Free Trial

84.67

79.65

87.08

88.02

80.56

Theragenics Quarterly Data
	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13
Total Assets	Get a 7-Day Free Trial															95.61	82.18	80.56	81.16	80.93

Theragenics Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Theragenics's Total Assets for the fiscal year that ended in Dec. 2012 is calculated as

Total Assets	=	Total Equity (A: Dec. 2012 )	+	Total Liabilities (A: Dec. 2012 )
	=	58.618	+	21.944
	=	80.56

Theragenics's Total Assets for the quarter that ended in Jun. 2013 is calculated as

Total Assets	=	Total Equity (Q: Jun. 2013 )	+	Total Liabilities (Q: Jun. 2013 )
	=	58.764	+	22.17
	=	80.93

Theragenics (FRA:THX) Total Assets Explanation

Total Assets is connected with ROA %.

Theragenics's annualized ROA % for the quarter that ended in Jun. 2013 is

ROA %	=	Net Income (Q: Jun. 2013 )	/	( (Total Assets (Q: Mar. 2013 )	+	Total Assets (Q: Jun. 2013 ))	/ count )
	=	-0.044	/	( (81.158	+	80.934)	/ 2 )
	=	-0.044	/	81.046
	=	-0.05 %

Note: The Net Income data used here is four times the quarterly (Jun. 2013) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Theragenics's Asset Turnover for the quarter that ended in Jun. 2013 is

	Asset Turnover
=	Revenue (Q: Jun. 2013 )	/	( (Total Assets (Q: Mar. 2013 )	+	Total Assets (Q: Jun. 2013 ))	/ count )
=	15.387	/	( (81.158	+	80.934)	/ 2 )
=	15.387	/	81.046
=	0.19

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Theragenics Total Assets Related Terms

Thank you for viewing the detailed overview of Theragenics's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Theragenics (FRA:THX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Theragenics Corporation (FRA:THX) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.theragenics.com

Theragenics Corporation is a Delaware Corporation formed in 1981. It is a medical device company serving the surgical products and cancer treatment markets, operate in two business segments; the surgical products segment and the brachytherapy seed segment. The Company's surgical products business manufactures markets and sells disposable devices utilized in certain surgical procedures. Its brachytherapy seed business manufactures markets and sells radioactive 'seeds' utilized in the treatment of early stage prostate cancer. Its surgical products business was built through the acquisitions of CP Medical Corp. in May 2005, Galt Medical Corporation in August 2006, and NeedleTech Products, Inc. in July 2008. The Company manufactures almost 3,500 products in this business as part of three broad product platforms; wound closure, vascular access and specialty needles. It serves a number of markets and applications, including, among other areas, interventional cardiology, interventional radiology, vascular surgery, orthopedics, plastic surgery, dental surgery, urology, veterinary medicine, pain management, endoscopy, and spinal surgery. With the exception of veterinary sutures, its surgical products hold relatively small market shares. Its products include both finished goods and components. The Company's products are sold mainly to original equipment manufacturers and to a network of distributors. The Company's facilities and operations are subject to extensive environmental, nuclear, regulatory and occupational health and safety laws at the federal, state and local levels. It is also subject to similar foreign laws and regulations under certain circumstances when its products are distributed outside of the United States.

Theragenics (FRA:THX) Headlines

No Headlines